论文部分内容阅读
目的分析研究无痛人流手术中使用异丙酚联合瑞芬太尼的临床效果。方法抽取近年来在我站进行无痛人流手术的孕妇120例,采用随机抽取模式,随机分为实验组和对照组,每组各60例。对照组对孕妇实施异丙酚进行麻醉,实验组在对照组的基础之上加入瑞芬太尼,对麻醉以后两组临床麻醉效果进行对比分析。结果两组孕妇使用药物以后2min BP、HR、SpO2都有明显降低,其中实验组2min BP、HR、SpO2明显低于对照组,两组间差异具有统计学意义(P<0.05);实验组孕妇苏醒时间显著低于对照组,两组间差异具有统计学意义(P<0.05);实验组孕妇满意度明显优于对照组,两组间差异具有统计学意义(P<0.05)。结论对无痛人流手术采用异丙酚联合瑞芬太尼共同治疗,可取得明显的临床效果,不良反应极少,且具有安全稳定性,使孕妇健康质量得到保障,具有临床推广价值。
Objective To analyze the clinical effect of using propofol combined with remifentanil in painless abortion. Methods Totally 120 pregnant women with painless abortion in our hospital in recent years were randomly divided into experimental group and control group with 60 cases in each group. In the control group, propofol was given to pregnant women for anesthesia. The experimental group was given remifentanil on the basis of the control group, and the clinical effects of anesthesia were compared between the two groups after anesthesia. Results The BP, HR and SpO2 of the two groups of pregnant women decreased significantly after 2 minutes of treatment, and the BP, HR and SpO2 in the experimental group were significantly lower than those in the control group at 2 minutes (P <0.05). The pregnant women in the experimental group The awakening time was significantly lower than that of the control group, with significant difference between the two groups (P <0.05). The satisfaction of pregnant women in the experimental group was significantly better than that of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusions The combination of propofol and remifentanil for painless abortion can achieve obvious clinical effect with little adverse reaction and safety and stability so that the health quality of pregnant women can be protected and has clinical popularization value.